Literature DB >> 26183384

Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.

Andrey Korshunov1,2, Frederick A Jakobiec3, Charles G Eberhart4,5, Volker Hovestadt6, David Capper1,2, David T W Jones7, Dominik Sturm7,8, Anna M Stagner3, Deepak P Edward4,5, Ralph C Eagle9, Alan D Proia10, Arend Koch11, Marina Ryzhova12, Anastasia Ektova13, Ulrich Schüller14, Olga Zheludkova15, Peter Lichter2,6, Andreas von Deimling1,2, Stefan M Pfister2,7,8, Marcel Kool7.   

Abstract

Intraocular medulloepithelioma (IO MEPL) is an uncommon embryonal neuroepithelial neoplasm of the eye. These ocular neoplasms have been compared with intracranial medulloepitheliomas or other histologic variants of CNS embryonal tumor with multilayered rosettes (CNS ETMR) due to their morphological mimicry. We performed comprehensive molecular analysis to explore the histogenetic and biologic relationships between 22 IO MEPL and 68 CNS ETMR. Routinely prepared paraffin-embedded samples were assessed for genome-wide methylation profiles using the Illumina Methylation 450k BeadChip array. We identified strong cytogenetic and epigenetic differences between ocular neoplasms and CNS ETMR. None of the IO MEPL cases displayed the ETMR-specific amplification of the C19MC locus. Instead, cytogenetic analysis of the IO MEPL showed numerous copy number aberrations which involved either whole chromosomes or chromosomal arms; recurrent aberrations in these tumors affected chromosomes 1p, 4, 8 and 16p. DNA methylation patterns were also strikingly different between these two tumor entities, suggesting that they do not share common origins and biological behaviors. Comparative cluster analysis of 198 pediatric CNS tumors and 22 IO MEPL revealed a clear demarcation of the CNS ETMR and IO MEPL profiles from other CNS entities. In conclusion, although IO MEPL shares some histopathological features with CNS ETMR, they manifest striking molecular diversity at the cytogenetic and epigenetic levels. Consequently they deserve a separate nosologic designation in future tumor classifications, where CNS MEPL could be designated as a histological variant of CNS ETMR.
© 2015 Japanese Society of Neuropathology.

Entities:  

Keywords:  brain; chromosomal aberrations; epigenetic; eye; medulloepithelioma

Mesh:

Year:  2015        PMID: 26183384     DOI: 10.1111/neup.12227

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  14 in total

1.  Nonteratoid Medulloepithelioma Presenting in a 78-Year-Old Male.

Authors:  Christopher K H Burris; Vasilios P Papastefanou; Caroline Thaung; Gordon Hay; Marianne Grantham; Victoria M L Cohen
Journal:  Ocul Oncol Pathol       Date:  2016-04-07

2.  Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.

Authors:  Adriana Olar; Khalida M Wani; Charmaine D Wilson; Gelareh Zadeh; Franco DeMonte; David T W Jones; Stefan M Pfister; Erik P Sulman; Kenneth D Aldape
Journal:  Acta Neuropathol       Date:  2017-01-27       Impact factor: 17.088

3.  On the Classification and Grading of Medulloepithelioma of the Eye.

Authors:  Robert M Verdijk
Journal:  Ocul Oncol Pathol       Date:  2016-02-13

4.  Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Authors:  Yanal Omari; Ahmad A Karkash; Razan A Mansour; Nisreen Amayiri; Maisa Swaidan; Maysa Al-Hussaini
Journal:  Childs Nerv Syst       Date:  2019-01-08       Impact factor: 1.475

5.  Clinical Efficacy of the Multilayered Skull Base Reconstruction Using In Situ Bone Flap in Endoscopic Endonasal Approach for Craniopharyngioma.

Authors:  Yuefei Zhou; Yue Hei; Jose M Soto; Tao Jin; Xiaofan Jiang; Dongxia Feng; Weiping Liu; Dakuan Gao
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-31

6.  12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.

Authors:  Kaishi Satomi; Hirokazu Takami; Shintaro Fukushima; Satoshi Yamashita; Yuko Matsushita; Yoichi Nakazato; Tomonari Suzuki; Shota Tanaka; Akitake Mukasa; Nobuhito Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga; Keiichi Kobayashi; Motoo Nagane; Toshihiko Iuchi; Koji Yoshimoto; Kaoru Tamura; Taketoshi Maehara; Keiichi Sakai; Kazuhiko Sugiyama; Kiyotaka Yokogami; Hideo Takeshima; Masahiro Nonaka; Akio Asai; Toshikazu Ushijima; Masao Matsutani; Ryo Nishikawa; Koichi Ichimura
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

Review 7.  Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors.

Authors:  Patrick Sin-Chan; Bryan K Li; Ben Ho; Adriana Fonseca; Annie Huang
Journal:  Curr Oncol Rep       Date:  2018-07-11       Impact factor: 5.075

8.  The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma.

Authors:  Sarah E Avedschmidt; Anna M Stagner; Ralph C Eagle; George J Harocopos; Yali Dou; Rajesh C Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

9.  Early Neuroblastic and Astrocytic Differentiation Demonstrated Immunohistochemically in a Small Intraocular Medulloepithelioma.

Authors:  Frederick A Jakobiec; Fouad R Zakka; Thanos Papakostas; Shizuo Mukai
Journal:  Ocul Oncol Pathol       Date:  2017-11-08

10.  Infantile medulloepithelioma in the lateral ventricle and cerebellopontine angle: Two case reports.

Authors:  Qiang Li; Ni Chen; Yan Ju
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.